Qlaira ® (Estradiol valerate/dienogest) is a combined oral contraceptive (OC) pill licensed for the treatment of heavymenstrual bleeding in women without organic pathology who desire oral contraception.
Reporting adverse events and quality complaints
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.
If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 01182063500 or email: pvuk@bayer.com
Further information is available on the “contact” tab at www.bayer.co.uk.
